Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It stores approximately 500,000 cord blood and cord tissue stem cells worldwide. The company markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.
Cryo-Cell International Dividend Announcement
• Cryo-Cell International announced a annually dividend of $0.25 per ordinary share which will be made payable on 2024-11-29. Ex dividend date: 2024-11-15
• Cryo-Cell International annual dividend for 2024 was $0.25
• Cryo-Cell International's trailing twelve-month (TTM) dividend yield is 2.82%
Cryo-Cell International Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-11-15 | $0.25 | annually | 2024-11-29 |
2022-09-01 | $0.90 | annually | 2022-09-09 |
Cryo-Cell International Dividend per year
Cryo-Cell International Dividend Yield
Cryo-Cell International current trailing twelve-month (TTM) dividend yield is 2.82%. Interested in purchasing Cryo-Cell International stock? Use our calculator to estimate your expected dividend yield:
Cryo-Cell International Financial Ratios
Cryo-Cell International Dividend FAQ
1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.
2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.
3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.
4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.
5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Place an order: Use the brokerage's trading platform to place an order to buy Cryo-Cell International stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.